Royalty Pharma Sub-Manager, LLC — 13F holdings

Royalty Pharma Sub-Manager, LLC reported 4 holdings worth $242M in its 13F filing for Q2 2026, filed August 21, 2026.

Largest positions

1. CYTK CYTOKINETICS INC — $83.5M (34.5%)
2. ZBIO ZENAS BIOPHARMA INC — $60.6M (25.1%)
3. KLRA KAILERA THERAPEUTICS INC — $54.1M (22.4%)
4. BHVN BIOHAVEN LTD — $43.7M (18.1%)